The global healthcare market is growing rapidly—it is expected to climb at a 6.9% CAGR over the next eight years, reaching more than $22.3 trillion by 2033. Its appeal to investors in the current market environment may also lie in its non-cyclical nature, thanks to resilient demand that is more related to health needs and demographics than to external economic conditions.
However, finding healthcare names poised for major growth may be difficult, considering that many of the largest legacy firms in the space are well beyond their days of big gains, and many others will remain highly speculative until (or if) they experience a significant commercial development or research breakthrough. The companies below might find the sweet spot for investors—they are neither among the biggest names in healthcare nor the most speculative, but they do have strong fundamentals and considerable upside potential.
